Dilon inks sales pact with PenRad

AuntMinnie.com staff writers
Aug 29, 2011

Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.

Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.
Latest in Breast
Acquisitions
Solis Mammography expands into Missouri
October 15, 2025
2025 10 14 Breast Qhdmi Ultrasound Thumbnail
qHDMI differentiates radial scars from invasive breast cancer
October 15, 2025
2025 10 14 Radiology Preop Mri Birads Thumbnail
Auditing preop MRIs is feasible under upcoming BI-RADS recommendations
October 14, 2025
Black Women Hands Mammography 400 (1)
Social adversity tied to TNBC incidence rates in Black women
October 14, 2025
Related Stories
2011 08 24 15 39 30 522 2011 08 25 Shutter Speed Breast Mri
MRI
Shutter-speed MRI more accurate for breast cancer diagnosis
2011 08 09 11 56 38 249 Stanford Breast Coil Image 02 Thumb
MRI
Stanford group shrinks MRI coil for better breast imaging
2011 07 29 08 17 13 510 2011 07 28 Bmj Thumb
Breast
Debate over breast screening to intensify after new BMJ study
2011 07 06 16 04 57 96 Li Mri Breast Thumb
MRI
CE-MRI predicts survival in breast cancer patients after chemo
More in Breast
Solis Mammography expands into Missouri
By AuntMinnie.com staff writers
The acquisition expands the company's footprint into its 23rd major market.
October 15, 2025
Acquisitions
qHDMI differentiates radial scars from invasive breast cancer
By Amerigo Allegretto
Angiogenesis-based biomarkers from ultrasound can differentiate between radial scar lesions and invasive breast cancer.
October 15, 2025
2025 10 14 Breast Qhdmi Ultrasound Thumbnail
Auditing preop MRIs is feasible under upcoming BI-RADS recommendations
By Amerigo Allegretto
Going by the upcoming BI-RADS manual resulted in metrics that were within expected ranges based on prior data.
October 14, 2025
2025 10 14 Radiology Preop Mri Birads Thumbnail
Social adversity tied to TNBC incidence rates in Black women
By Amerigo Allegretto
Black women in the U.S. who face more social adversity have higher incidence rates of triple-negative breast cancer (TNBC).
October 14, 2025
Black Women Hands Mammography 400 (1)
Breast tumor incidence trends similar for Black women in Ghana, U.S.
By Amerigo Allegretto
New data from the NCI finds that women in Ghana and Black women in the U.S. have similar breast tumor trends.
October 13, 2025
Patient African American Woman 400
Poll finds voters view ABCD Act favorably
By AuntMinnie.com staff writers
The Access to Breast Cancer Diagnosis (ABCD) Act would require coverage of supplemental breast exams.
October 10, 2025
Pink Ribbon Social
Lobular breast cancer incidence rising
By Amerigo Allegretto
Invasive lobular breast cancer incidence has risen by between 2.5% and 4.4% among women of various ethnic and racial backgrounds.
October 7, 2025
Breast Cancer2 400
Missed previous mammography screening linked to worse disease outcomes
By Amerigo Allegretto
Researchers found that women who did not attend their previous screening had larger tumors and poorer disease-specific survival.
October 3, 2025
Mammogram Dense Breasts Cropped
False-positive DBT findings differ between AI, radiologists
By Amerigo Allegretto
False-positive DBT findings differed between AI and radiologists in population-based breast cancer screening.
October 2, 2025
2025 10 02 Shahrvini Ai Vs Radiologist False Positives Thumbnail
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Study finds AI not cost-effective for breast cancer screening
By Amerigo Allegretto
AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
Adding MBI to DBT finds more breast cancers
By Amerigo Allegretto
Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.
September 23, 2025
Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).
Page 1 of 574
Next Page